Physician profile
Caleb Poston
NPI 1316326101
$2,047.99
in general payments reported to CMS, 2019-2025
9 companies · $347 in 2025
The $347 reported for 2025 was more than what 86% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $279 · 2020: $171 · 2021: $241 · 2022: $487 · 2023: $191 · 2024: $332 · 2025: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $720 · Education: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $720.19 |
| Education | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $953.43 | 2019-2025 | |
| Zimvie INC. | $347.49 | 2024-2025 | |
| Zimmer Biomet Holdings, INC. | $282.68 | 2019-2021 | |
| Nobel Biocare USA | $128.74 | 2019-2023 | Nobelactive |
| Geistlich Pharma, North America, INC. | $123.59 | 2022 | |
| Gc America INC. | $114.64 | 2023 | Cytrans |
| Biohorizons Implant Systems INC. | $48.22 | 2021 | |
| Philips North America LLC | $26.45 | 2019-2024 | (E55) Oral Health Care Und |
| Salvin Dental Specialties, INC. | $22.75 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caleb Poston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.